Quanterix Corporation develops ultra-sensitive detection systems for use in research and in-vitro diagnostics. The company offers automated immunoassay technology for detection and quantification of biomarkers in in-vitro and companion diagnostics and blood screening. Its products are used in life science, oncology, and neurology research in the United States. Quanterix Corporation was formerly known as Digital Genomics Inc. and changed its name to Quanterix Corporation in August 2007. The company is based in Lexington, Massachusetts.